DePuy AcroMed to Buy Link Spine Group for $325 Million

In a move that will give the company exclusive worldwide rights to a widely used artificial disc, DePuy AcroMed (Raynham, MA, USA) has agreed to acquire Link Spine Group (Branford, CT, USA) for a US$325 million upfront payment and further payments contingent upon achievement of regulatory and other milestones. DePuy Acromed is a Johnson & Johnson company.

The principal product of Link Spine Group is the SB Charite artificial disc, approved and marketed in more than 30 countries worldwide. The disc is designated by the US Food and Drug Administration (FDA) with an Investigational Device Exemption in clinical studies.

"The SB Charite artificial disc represents an important advancement in the treatment of spinal disorders,” said Ncholas Valeriani, group chairman with management responsibility for the DePuy franchise. "For many patients, total disc arthroplasty should provide a significant medical benefit. This investment underscores DePuy's commitment to innovative technology and advancing the standard of care for patients around the world.”





Related Links:
DePuy Acromed
Link Spine Group